NASDAQ Primary Care Market News

Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404

-Meets Co-Primary Endpoint of Specificity; 1404 Successfully Identifies Patients Without Clinically Significant Prostate Cancer--Co-Primary ...

Shire Granted EU Marketing Authorization for Veyvondi® for Adults With Von Willebrand Disease

SHIRE GRANTED EU MARKETING AUTHORIZATION FOR VEYVONDI® [VONICOG ALFA, RECOMBINANT VON WILLEBRAND FACTOR] FOR ...

Cyfluent Achieves EHNAC Cloud-Enabled Accreditation

CEAP accreditation offers a higher level of stakeholder confidence for organizations under competitive pressures ...

Integra LifeSciences Selected for Healogics iSupply℠ Program

PLAINSBORO, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a ...

Flexion Therapeutics Announces Publication of Phase 2 Diabetes Data in September Issue of Rheumatology

Phase 2 data evaluating ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in patients with Type ...

Results of interventional study support the use of suPARnostic® Quick Triage in emergency departments

Press Release                                                                                                                                    Birkerød, 10 September 2018 Today, at the 12th European Congress of Emergency ...